Atossa Therapeutics (ATOS) SEC Filings & 10K Form $0.96 -0.02 (-1.66%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Recent Atossa Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView12/10/20248:05 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/12/202412:32 PMAtossa Therapeutics (Subject)VANGUARD GROUP INC (Filed by)Form SC 13G/A11/04/202410:27 AMAtossa Therapeutics (Subject)VANGUARD GROUP INC (Filed by)Form SC 13G/A11/04/20245:35 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/22/20242:24 PMAtossa Therapeutics (Subject)BlackRock, Inc. (Filed by)Form SC 13G08/12/20248:00 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/12/20248:05 AMAtossa Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/23/202411:15 PMAtossa Therapeutics (Filer)Form EFFECT05/23/20248:00 AMAtossa Therapeutics (Filer)Form DEF 14A05/14/20243:46 PMAtossa Therapeutics (Filer)Form DEL AM05/13/20248:00 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/13/20248:05 AMAtossa Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/10/20248:00 AMAtossa Therapeutics (Filer)Form PRE 14A05/10/20248:04 AMAtossa Therapeutics (Filer)Form ARS03/18/20247:35 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/14/20247:30 PMAtossa Therapeutics (Issuer)Cigler Tessa (Reporting)Form 3Initial statement of beneficial ownership of securities 03/14/20247:35 PMAtossa Therapeutics (Issuer)Cigler Tessa (Reporting)Form 4Statement of changes in beneficial ownership of securities 03/12/20247:30 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies PureTech Health 10Q Form Humacyte 10Q Form AnaptysBio 10Q Form CorMedix 10Q Form Mereo BioPharma Group 10Q Form Xeris Biopharma 10Q Form ABIVAX Société Anonyme 10Q Form MeiraGTx 10Q Form Cartesian Therapeutics 10Q Form Monte Rosa Therapeutics 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:ATOS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atossa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atossa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATOS Stock Alerts